Newly Approved Weekly and Monthly Buprenorphine: A Primer for Clinicians
January 31, 2024
12:00 pm
1:00 pm
ET
Presenter(s):
Michelle Lofwall, MD

Target Audience: This activity was developed to meet the needs of physicians, nurses and interprofessional healthcare providers.

Discussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues.

Jointly Accredited Provider

In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit for this activity is designated for learners in the following ways:

IPCE Credit

IPCE Credit

This activity was planned by and for the healthcare team, and learners will receive 1 (one) Interprofessional Continuing Education credits for learning and change.

Physician Designation Statement

American Academy of Addiction Psychiatry designates this live activity for a maximum of one (1) AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education Statement

American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider # 4008192. This program is approved for up to one (one) Nursing Contact Hour.

Other Health Professionals

Participants will receive a Certificate of Attendance stating this program is designated for 1.0 hour AMA PRA Category 1 Credit™. This credit is accepted by the AAPA and the AANP.

Organizer(s):
American Academy of Addiction Psychiatry